Patents-Review.com
ClassID:

97055 ⎘

C07K14/70596 - page 3 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants Molecules with a "CD"-designation not provided for elsewhere

Recent Application in this class:
#601
20200392457
2020-12-17

METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE

 #602
20200392456
2020-12-17

Regulatory T cells genetically modified for the lymphotoxin alpha gene and uses thereof

 #603
20200392219
2020-12-17

EXTRACELLULAR VESICLES COMPRISING MEMBRANE-TETHERED TGF-BETA, COMPOSITIONS AND METHODS OF USE THEREOF

 #604
20200390816
2020-12-17

METHODS FOR ACTIVATION AND EXPANSION OF NATURAL KILLER CELLS AND USES THEREOF

 #605
20200390700
2020-12-17

Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

 #606
20200384026
2020-12-10

Polynucleotides encoding rituximab-resistant chimeric antigen receptors

 #607
20200377589
2020-12-03

Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy

 #608
20200377570
2020-12-03

LAMP constructs

 #609
20200369743
2020-11-26

METHODS AND COMPOSITIONS FOR CHIMERIC ANTIGEN RECEPTOR TARGETING CANCER CELLS

 #610
20200362052
2020-11-19

COMPOSITIONS AND METHODS FOR TREATING TOLL-LIKE RECEPTOR-DRIVEN INFLAMMATORY DISEASES

 #611
20200360434
2020-11-19

Nucleic acids encoding chimeric receptor comprising NKP30 receptor and CD28 and CD3 zeta domains and human T cell containing

 #612
20200354471
2020-11-12

TETRAVALENT TLR9 BISPECIFIC ANTIBODY

 #613
20200354466
2020-11-12

NEUTRALIZING ANTIBODIES AND METHODS OF USE THEREOF

 #614
20200345774
2020-11-05

Engineered phagocytic receptor compositions and methods of use thereof

 #615
20200345773
2020-11-05

Engineered phagocytic receptor compositions and methods of use thereof

 #616
20200339659
2020-10-29

PDL1 PEPTIDES FOR USE IN CANCER VACCINES

 #617
20200338130
2020-10-29

Genetically engineered hematopoietic stem cells and uses thereof

 #618
20200338124
2020-10-29

CELL

 #619
20200325212
2020-10-15

Tumor-selective CTLA-4 antagonists

 #620
20200318071
2020-10-08

Genetically engineered hematopoietic stem cells and uses thereof

 #621
20200316190
2020-10-08

Method of inhibiting enveloped virus binding to target cells by incorporating P-selectin glycoprotein ligand-1 (PSGL-1) into virions

 #622
20200308305
2020-10-01

Chimeric engulfment receptor molecules and methods of use

 #623
20200306304
2020-10-01

Tn-MUC1 chimeric antigen receptor (CAR) T cell therapy

 #624
20200299743
2020-09-24

Early post-transfection isolation of cells (EPIC) for biologics production

 #625
20200299686
2020-09-24

Methods and Compositions for Engineering Synthetic Bioswitches for Remote Control of Biological Activity

 #626
20200297830
2020-09-24

SEQUENCE ARRANGEMENTS AND SEQUENCES FOR NEOEPITOPE PRESENTATION

 #627
20200291129
2020-09-17

Methods and compositions for diagnosing and treating diseases

 #628
20200291125
2020-09-17

Chimeric antigen receptors, compositions, and methods

 #629
20200291118
2020-09-17

Anti-PD-1/CD47 bispecific antibody and application thereof

 #630
20200291076
2020-09-17

Compositions and methods for targeting MASAs to treat cancers with spliceosome mutations

 #631
20200289614
2020-09-17

Compositions containing protein loaded exosome and methods for preparing and delivering the same

 #632
20200283542
2020-09-10

ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA

 #633
20200283496
2020-09-10

TIGIT- and light-based chimeric proteins

 #634
20200282035
2020-09-10

Chimeric antigen receptor specific for tumor cells

 #635
20200277354
2020-09-03

Modulators of notch signaling and methods of use thereof

 #636
20200270590
2020-08-27

P97-IDS fusion proteins

 #637
20200270324
2020-08-27

SIRP-gamma polypeptide compositions and treatment of cancer

 #638
20200270321
2020-08-27

ANTIGEN BINDING MOLECULES COMPRISING A TRIMERIC TNF FAMILY LIGAND

 #639
20200262891
2020-08-20

CD33 exon 2 deficient donor stem cells for use with CD33 targeting agents

 #640
20200262879
2020-08-20

METHODS AND COMPOSITIONS TO ENHANCE THE IMMUNOGENICITY OF TUMORS

 #641
20200255541
2020-08-13

Compositions and methods for treatment of cancer

 #642
20200247904
2020-08-06

Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer

 #643
20200239543
2020-07-30

Constructs having a SIRP-α domain or variant thereof

 #644
20200236914
2020-07-30

PATHOGEN-RESISTANT ANIMALS HAVING MODIFIED AMINOPEPTIDASE N (ANPEP) GENES

 #645
20200231954
2020-07-23

Gene therapies for lysosomal disorders

 #646
20200231649
2020-07-23

TCRS SPECIFIC FOR MINOR HISTOCOMPATIBILITY (H) ANTIGEN HA-1 AND USES THEREOF

 #647
20200222556
2020-07-16

Preparation of therapeutic exosomes using membrane proteins

 #648
20200222503
2020-07-16

Methods of making and using extracellular domain-based chimeric proteins

 #649
20200216810
2020-07-09

CD1D-restricted NKT cells as a platform for off-the-shelf cancer immunotherapy

 #650
20200216562
2020-07-09

Integral membrane protein display on poxvirus extracellular enveloped virions

 #651
20200216513
2020-07-09

Fusion protein

 #652
20200216494
2020-07-09

Method of treatment

 #653
20200209247
2020-07-02

METHODS FOR IDENTIFYING MYELOMA TUMOR-INITIATING CELLS AND TARGETED THERAPY

 #654
20200209240
2020-07-02

CD19CART CELLS ELIMINATE MYELOMA CELLS THAT EXPRESS VERY LOW LEVELS OF CD19

 #655
20200207833
2020-07-02

Therapeutic delivery vesicles

 #656
20200197485
2020-06-25

Methods of use of soluble CD24 for treating immune related adverse events in cancer therapies

 #657
20200197484
2020-06-25

COMPOSITIONS, KITS AND METHODS FOR TREATMENT OF COMPLEMENT-RELATED DISORDERS

 #658
20200187468
2020-06-18

Non-human animals having a humanized signal-regulatory protein gene

 #659
20200181235
2020-06-11

METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION

 #660
20200172870
2020-06-04

CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE

 #661
20200157241
2020-05-21

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

 #662
20200157221
2020-05-21

Oncolytic viral delivery of therapeutic polypeptides

 #663
20200157179
2020-05-21

CD47 BLOCKADE THERAPY

 #664
20200149070
2020-05-14

METHODS AND COMPOSITIONS FOR GENOME EDITING

 #665
20200148745
2020-05-14

Gene therapy vectors for treatment of Danon disease

 #666
20200140544
2020-05-07

Chimeric antigen receptor (CAR) comprising a CD19-binding domain

 #667
20200140520
2020-05-07

IMMUNOSUPPRESSIVE TGF-B SIGNAL CONVERTER

 #668
20200140519
2020-05-07

T-cell modulatory multimeric polypeptides and methods of use thereof

 #669
20200138869
2020-05-07

Genetically engineered hematopoietic stem cells and uses thereof

 #670
20200138866
2020-05-07

Non-natural NKG2D receptors that do not directly signal the cells to which they are attached

 #671
20200137992
2020-05-07

Porcine reproductive and respiratory syndrome virus resistant animals

 #672
20200123254
2020-04-23

Compositions and methods for treating cancer with anti-CD19 immunotherapy

 #673
20200116726
2020-04-16

PANCREATIC CANCER TARGETS AND USES THEREOF

 #674
20200115455
2020-04-16

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

 #675
20200108098
2020-04-09

ANTI-CD83 CHIMERIC ANTIGEN RECEPTOR EXPRESSING T REGULATORY CELLS

 #676
20200102540
2020-04-02

CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE

 #677
20200101111
2020-04-02

Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies

 #678
20200101106
2020-04-02

IN VIVO PRIMING OF NATURAL KILLER CELLS

 #679
20200095339
2020-03-26

Recombinant bi-functional fusion protein and use thereof

 #680
20200093865
2020-03-26

Genetically engineered hematopoietic stem cells and uses thereof

 #681
20200093863
2020-03-26

Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies

 #682
20200093861
2020-03-26

ANTIGEN BINDING RECEPTOR FORMATS

 #683
20200087377
2020-03-19

Multifunctional Fusion Protein and Applications Thereof

 #684
20200087367
2020-03-19

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE

 #685
20200085962
2020-03-19

Dendrimer conjugates for coating cells

 #686
20200085869
2020-03-19

THERAPEUTIC REGIMENS FOR CHIMERIC ANTIGEN RECEPTOR THERAPIES

 #687
20200078399
2020-03-12

Chimeric antigen receptors targeting BCMA and methods of use thereof

 #688
20200071726
2020-03-05

Gene therapies for lysosomal disorders

 #689
20200071668
2020-03-05

Exosome for stimulating T cell and pharmaceutical use thereof

 #690
20200071401
2020-03-05

Multipartite signaling proteins and uses thereof

 #691
20200071399
2020-03-05

MULTIPARTITE SIGNALING PROTEINS AND USES THEREOF

 #692
20200071382
2020-03-05

TGF-BETA SUPERFAMILY HETEROMULTIMERS AND USES THEREOF

 #693
20200071380
2020-03-05

COMBINATION THERAPIES COMPRISING SIRP ALPHA-BASED CHIMERIC PROTEINS

 #694
20200062818
2020-02-27

Bifunctional fusion proteins to inhibit angiogenesis in tumor microenvironment and to activate adaptive immune responses and the genes and uses thereof

 #695
20200055916
2020-02-20

Soluble CD33 for treating myelodysplastic syndromes (MDS)

 #696
20200054747
2020-02-20

MRNA combination therapy for the treatment of cancer

 #697
20200054730
2020-02-20

Targeted neoepitope vectors and methods therefor

 #698
20200054725
2020-02-20

Breast and ovarian cancer vaccines

 #699
20200045945
2020-02-13

Swine Comprising Modified CD163 and Associated Methods

 #700
20200040059
2020-02-06

SECRETABLE VARIANT IMMUNOMODULATORY PROTEINS AND ENGINEERED CELL THERAPY

 #701
20200038508
2020-02-06

Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein

 #702
20200038441
2020-02-06

Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies

 #703
20200032207
2020-01-30

Gamma delta T cells and a method of augmenting the tumoricidal activity of the same

 #704
20200031902
2020-01-30

Antitumor peptide and use thereof

 #705
20200030416
2020-01-30

Synthetic platelets

 #706
20200023007
2020-01-23

Compositions and methods targeting complement component 3 for inhibiting tumor growth

 #707
20200018745
2020-01-16

MonoMac-1 cells expressing CD16 and CD163

 #708
20200016250
2020-01-16

Methods and compositions using recombinant dendritic cells for cancer therapy

 #709
20190389927
2019-12-26

CD147 AS RECEPTOR FOR PILUS-MEDIATED ADHESION OF MENINGOCOCCI TO VASCULAR ENDOTHELIA

 #710
20190382507
2019-12-19

Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer

 #711
20190375818
2019-12-12

Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms

 #712
20190367929
2019-12-05

CTLA4/PD1 targeted/immunomodulatory fusion proteins

 #713
20190367579
2019-12-05

TIGIT- AND LIGHT-BASED CHIMERIC PROTEINS

 #714
20190365806
2019-12-05

IMMUNOLOGICALLY DISCERNIBLE CELL SURFACE VARIANTS FOR USE IN CELL THERAPY

 #715
20190361039
2019-11-28

Methods for increasing palatability of pet foodstuff

 #716
20190359989
2019-11-28

FUSION PROTEIN AND APPLICATIONS THEREOF

 #717
20190359708
2019-11-28

COMPOSITIONS COMPRISING SOLUBLE CD84 OR ANTI-CD84 ANTIBODIES AND METHODS FOR DIAGNOSING AND TREATING B-CLL

 #718
20190352372
2019-11-21

SIRPalpha-41BBL fusion protein and methods of use thereof

 #719
20190350993
2019-11-21

Recombinant oncolytic virus, synthetic DNA sequence, and application thereof

 #720
20190350981
2019-11-21

METHODS OF TREATING MULTIPLE SCLEROSIS USING AUTOLOGOUS T CELLS

 #721
20190345516
2019-11-14

METHODS FOR TREATING EYE DISEASE

 #722
20190338028
2019-11-07

CD47-CAR-T cells

 #723
20190336544
2019-11-07

Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells

 #724
20190330306
2019-10-31

Compositions and Methods for Modulating the Immune System

 #725
20190315834
2019-10-17

SIRP alpha-CD70 fusion protein and methods of use thereof

 #726
20190315807
2019-10-17

Virus-like particles with high-density coating for inducing the expression of antibodies

 #727
20190313615
2019-10-17

Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)

 #728
20190309086
2019-10-10

TLR9-binding chimeric antigen receptors

 #729
20190309061
2019-10-10

MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF

 #730
20190307841
2019-10-10

Use of CD24 for lowering low-density lipoprotein cholesterol levels

 #731
20190307797
2019-10-10

Chimeric antigen receptor and CAR-T cells that bind BCMA

 #732
20190298821
2019-10-03

Nucleic Acids for Treatment of Peanut Allergies

 #733
20190292238
2019-09-26

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell

 #734
20190289835
2019-09-26

Mouse Models Having a Knockin Scavenger Receptor Class B Type I

 #735
20190284532
2019-09-19

Feeder cell and method for growing gamma delta T cells by using same

 #736
20190284298
2019-09-19

USE OF ANTIBODY-COUPLED T CELL RECEPTOR (ACTR) WITH MULTIPLE ANTI-CANCER ANTIBODIES IN CANCER TREATMENT

 #737
20190276556
2019-09-12

Integral membrane protein display on poxvirus extracellular enveloped virions

 #738
20190269756
2019-09-05

CD47 blockade therapy by HDAC inhibitors

 #739
20190263889
2019-08-29

CD80 and CD86 binding protein compositions and uses thereof

 #740
20190256573
2019-08-22

Nanoparticles Having Molecules That Bind or Block PD-L1 and Uses In Treating Cancer

 #741
20190255185
2019-08-22

High affinity CXCR4 selective binding conjugate and method for using the same

 #742
20190255108
2019-08-22

Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof

 #743
20190255082
2019-08-22

Enhancement of CD47 blockade therapy by proteasome inhibitors

 #744
20190248914
2019-08-15

Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases

 #745
20190248894
2019-08-15

Bi-specific molecule for cell-specific Notch inhibition and related methods and compositions

 #746
20190247432
2019-08-15

Genetically modified immune cells targeting NY-ESO-1 and methods of use thereof

 #747
20190241643
2019-08-08

Specific bifunctional BY-001 (active composition of homomultimer of chimeric protein pd-L1 / fc-gamma1) down regulates the activation of human immune cells and the use thereof

 #748
20190240343
2019-08-08

Platform for enhanced targeted delivery

 #749
20190218273
2019-07-18

Nucleic acid encoding angiopoietin-2 specific Tie2 receptor

 #750
20190209671
2019-07-11

Specific Chimeric Antigen Receptor T Cells Targeting to CD47, Preparation Method and Application Thereof

 #751
20190209611
2019-07-11

Chimeric antigen receptor specific for tumor cells

 #752
20190203170
2019-07-04

Avian Cells for Improved Virus Production

 #753
20190202878
2019-07-04

Complement inhibitors and uses thereof

 #754
20190194330
2019-06-27

Methods of sensitizing cancer to immunotherapy

 #755
20190194292
2019-06-27

Enveloped virus resistant to complement inactivation for the treatment of cancer

 #756
20190194283
2019-06-27

Immunomodulatory polypeptides and related compositions and methods

 #757
20190194281
2019-06-27

Vesicles comprising lectins expressed on the surface and methods of use thereof to deliver an agent to autophagic and apoptotic cells

 #758
20190192669
2019-06-27

TLR9 targeted therapeutics

 #759
20190187158
2019-06-20

Methods for increasing palatability of pet foodstuff

 #760
20190185860
2019-06-20

Manipulated immunoregulatory element and immunity altered thereby

 #761
20190185532
2019-06-20

INHIBITORS

 #762
20190177746
2019-06-13

Retroviral and lentiviral vectors

 #763
20190177398
2019-06-13

Chimeric antigen receptors having GITR intracellular domain as co-stimulatory domain

 #764
20190175654
2019-06-13

CD155 variant immunomodulatory proteins and uses thereof

 #765
20190175652
2019-06-13

Modified T lymphocytes comprising a BAFF antibody-inducible caspase and methods of apoptosis

 #766
20190169621
2019-06-06

Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins

 #767
20190169266
2019-06-06

Constructs having a SIRP-alpha domain or variant thereof

 #768
20190169265
2019-06-06

Soluble glycoprotein V for treating thrombotic diseases

 #769
20190153109
2019-05-23

Chimeric antigen receptors and uses thereof

 #770
20190153063
2019-05-23

Methods and compositions for chimeric antigen receptor targeting cancer cells

 #771
20190144522
2019-05-16

Anti-CD7 chimeric antigen receptor and method of use thereof

 #772
20190142935
2019-05-16

Formulation containing TLR agonist and methods of use

 #773
20190135894
2019-05-09

COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHODS OF USE THEREOF

 #774
20190135865
2019-05-09

Agonist agents of CD47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death

 #775
20190133964
2019-05-09

Polypeptide nano-bubbles and preparation method and application thereof

 #776
20190125834
2019-05-02

Recombinant fusion protein containing an anti-PD-L1 antibody

 #777
20190124895
2019-05-02

Non-human animals having a humanized signal-regulatory protein gene

 #778
20190119379
2019-04-25

Cancer gene therapy targeting CD47

 #779
20190119353
2019-04-25

IMMUNOTHERAPEUTICS FOR CANCER AND AUTOIMMUNE DISEASES

 #780
20190119345
2019-04-25

Compositions and methods for targeted cytokine delivery

 #781
20190117792
2019-04-25

Preparation of therapeutic exosomes using membrane proteins

 #782
20190117765
2019-04-25

Lysosomal targeting of antigens employing nucleic acids encoding lysosomal membrane polypeptide/antigen chimeras

 #783
20190112388
2019-04-18

Integral membrane protein display on poxvirus extracellular enveloped virions

 #784
20190112386
2019-04-18

Compositions and methods for tumor transduction

 #785
20190112372
2019-04-18

Multipartite signaling proteins and uses thereof

 #786
20190112351
2019-04-18

EXOSOME-TARGETED DNA VACCINE

 #787
20190112350
2019-04-18

Peptidic TGF-beta antagonists

 #788
20190111111
2019-04-18

Treatment of Cerebral Cavernous Malformations

 #789
20190106492
2019-04-11

Compositions and methods for treating cancer with anti-CD19 immunotherapy

 #790
20190092837
2019-03-28

Prion protein-dendrimer conjugates for use in treatment of alzheimer disease

 #791
20190092812
2019-03-28

Cyclic peptide conjugates and methods of use

 #792
20190085081
2019-03-21

CHIMERIC ANTIGEN RECEPTOR

 #793
20190082662
2019-03-21

Pathogen-resistant animals having modified CD163 genes

 #794
20190076492
2019-03-14

Immunity-inducing agent

 #795
20190070262
2019-03-07

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

 #796
20190062450
2019-02-28

Engineered antigen presenting cells and uses thereof

 #797
20190062387
2019-02-28

Method for establishing eukaryotic expression cell line of CD36 mutant gene that encodes CD36 deficiency

 #798
20190062380
2019-02-28

Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof

 #799
20190060483
2019-02-28

Preparation of therapeutic exosomes using membrane proteins

 #800
20190055318
2019-02-21

Eliminating MHC restriction from the T cell receptor as a strategy for immunotherapy

 #801
20190054190
2019-02-21

Methods for the treatment of Danon disease and other disorders of autophagy

 #802
20190054151
2019-02-21

Synthetic platelets

 #803
20190048342
2019-02-14

CROSS-REGULATION OF TYPE I INTERFERON SIGNALING PATHWAYS

 #804
20190048083
2019-02-14

Regulatory T cell mediator proteins and uses thereof

 #805
20190048082
2019-02-14

Oncolytic viral delivery of therapeutic polypeptides

 #806
20190023803
2019-01-24

Therapeutic anti-CD9 antibody

 #807
20190023765
2019-01-24

Method for producing erythrocyte proteins

 #808
20190016783
2019-01-17

Methods of use of soluble CD24 for therapy of rheumatoid arthritis

 #809
20190010462
2019-01-10

Stem cells expressing mesenchymal and neuronal markers, compositions thereof, and methods of preparation thereof

 #810
20190010211
2019-01-10

Fusion proteins comprising partial tetraspanin sequences and a system thereof for presenting peptides on the cell surface

 #811
20190008897
2019-01-10

COMPOSITIONS AND METHODS FOR PRODUCING PRO-INFLAMMATORY MACROPHAGES

 #812
20190002527
2019-01-03

Methods and compositions for the inhibition of TRPV4

 #813
20180371100
2018-12-27

ANTIBODY WHICH SPECIFICALLY BINDS TO HUMAN CRTH2

 #814
20180371056
2018-12-27

Multi-Span Chimeric Antigen Receptor

 #815
20180371053
2018-12-27

Methods and compositions for chimeric antigen receptor targeting cancer cells

 #816
20180369410
2018-12-27

Dendrimer-exosome hybrid nanoparticles as a delivery platform

 #817
20180369374
2018-12-27

MRNA combination therapy for the treatment of cancer

 #818
20180368374
2018-12-27

Porcine reproductive and respiratory syndrome virus resistant animals

 #819
20180362940
2018-12-20

Expression of novel cell tags

 #820
20180355053
2018-12-13

SIRP alpha-antibody fusion proteins

 #821
20180355018
2018-12-13

Compounds for treating neurodegenerative proteinopathies

 #822
20180355017
2018-12-13

Compositions and methods for internalizing enzymes

 #823
20180355016
2018-12-13

Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein

 #824
20180355013
2018-12-13

NKG2D-IG fusion protein for cancer immunotherapy

 #825
20180353625
2018-12-13

RNA transcription vector and uses thereof

 #826
20180346929
2018-12-06

Viral vector targeting cancer stem cells

 #827
20180320135
2018-11-08

OX40L-JAGGED-1 CHIMERIC POLYPEPTIDES AND USES THEREOF

 #828
20180319861
2018-11-08

Combination therapy for malignant diseases

 #829
20180318350
2018-11-08

Immune cells with DNMT3A gene modifications and methods related thereto

 #830
20180313821
2018-11-01

CONSTRUCTION METHOD OF CELL MODELS FOR DETECTING PYROGENS, CELL MODELS AND PYROGEN DETECTION KITS

 #831
20180312819
2018-11-01

Protein inhibitors to complement and VEGF pathways and methods of use thereof

 #832
20180311369
2018-11-01

Peptide-based molecules for modulating car expression or accessibility and uses thereof

 #833
20180289779
2018-10-11

Method for producing ACE2 polypeptide

 #834
20180289771
2018-10-11

Methods for treating cancer using PS-targeting antibodies with immuno-oncology agents

 #835
20180282426
2018-10-04

Neutralizing antibodies and methods of use thereof

 #836
20180273608
2018-09-27

Multi-epitopic construct

 #837
20180273593
2018-09-27

Chimeric inhibitor molecules of complement activation

 #838
20180265593
2018-09-20

Antibodies and chimeric antigen receptors specific for ROR1

 #839
20180265589
2018-09-20

Glycated CD59 peptides, their preparation, and uses thereof

 #840
20180258156
2018-09-13

Endoglin polypeptides and uses thereof

 #841
20180251568
2018-09-06

CSGP4—specific chimeric antigen receptor for cancer

 #842
20180249689
2018-09-06

Method of using mouse having a humanized cluster of differentiation 47 gene

 #843
20180244749
2018-08-30

Immunomodulatory proteins with tunable affinities

 #844
20180237482
2018-08-23

Fusion protein or conjugated protein, intracellular delivery carrier, partial peptide, cell membrane permeation enhancer, DNA, and vector

 #845
20180236053
2018-08-23

Cells for immunotherapy engineered for targeting CD38 antigen and for CD38 gene inactivation

 #846
20180230225
2018-08-16

Chimeric antigen receptors based on single domain antibodies and methods of use thereof

 #847
20180215806
2018-08-02

Tumor-selective CTLA-4 antagonists

 #848
20180208658
2018-07-26

CONSTRUCTS TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF

 #849
20180200350
2018-07-19

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

 #850
20180188251
2018-07-05

SRM/MRM assays for cancer

 #851
20180187211
2018-07-05

Methods and compositions for combination immunotherapy

 #852
20180187210
2018-07-05

Non-HLA matched humanized NSG mouse model with patient-derived xenograft

 #853
20180185434
2018-07-05

IMMUNE CHECKPOINT CHIMERIC ANTIGEN RECEPTORS THERAPY

 #854
20180185417
2018-07-05

Compositions and methods for enrichment of cells

 #855
20180170999
2018-06-21

BTLA fusion protein agonists and uses thereof

 #856
20180170998
2018-06-21

AML antigens and uses thereof

 #857
20180162929
2018-06-14

CD137 binding fibronectin type III domains

 #858
20180162928
2018-06-14

PD-L1 binding fibronectin type III domains

 #859
20180161369
2018-06-14

COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY

 #860
20180160663
2018-06-14

Genetically modified mouse whose genome comprises a humanized CD274 gene

 #861
20180160662
2018-06-14

Transgenic Immunodeficient Mouse Expressing Human SIRP-alpha

 #862
20180160661
2018-06-14

Siglec transgenic mice and methods of use thereof

 #863
20180155405
2018-06-07

SIRP-gamma polypeptide compositions and methods of use

 #864
20180147240
2018-05-31

NKP30 receptor targeted therapeutics

 #865
20180142035
2018-05-24

Compositions and methods for treatment of cancer

 #866
20180141994
2018-05-24

TOLL-LIKE RECEPTOR 2 BINDING EPITOPE AND BINDING MEMBER THERETO

 #867
20180139941
2018-05-24

Non-human animals having a humanized signal-regulatory protein gene

 #868
20180134754
2018-05-17

Exosomes and methods of making and using the same

 #869
20180127776
2018-05-10

Ligand Matched Transcription Control, Control Devices, and Solute Carriers

 #870
20180127480
2018-05-10

High affinity CD47 analogs

 #871
20180117117
2018-05-03

Compositions containing protein loaded exosome and methods for preparing and delivering the same

 #872
20180110828
2018-04-26

Use of CD24 for lowering low-density lipoprotein cholesterol levels

 #873
20180105573
2018-04-19

NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR

 #874
20180104187
2018-04-19

Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer

 #875
20180100163
2018-04-12

Nucleic acid construct

 #876
20180094044
2018-04-05

Chimeric antigen receptors

 #877
20180094027
2018-04-05

Dipeptidyl peptidase-IV (DPPIV), inhibitory peptide compound, composition containing the same, and production method for the same

 #878
20180092920
2018-04-05

METHOD FOR TREATING TAU PROTEIN-MEDIATED DEGENERATIVE NEURONAL DISEASE

 #879
20180086813
2018-03-29

Peptides that inhibit syndecan-1 activation of VLA-4 and IGF-1R

 #880
20180079815
2018-03-22

Constructs targeting AFP peptide/MHC complexes and uses thereof

 #881
20180067128
2018-03-08

Biomarkers for diagnosis and prognosis of corneal ectatic disorders

 #882
20180066057
2018-03-08

Epidermal growth factor receptor targeted/immunomodulatory fusion proteins and methods of use for them

 #883
20180057594
2018-03-01

PSEUDOTYPED ONCOLYTIC VIRAL DELIVERY OF THERAPEUTIC POLYPEPTIDES

 #884
20180050111
2018-02-22

Dendrimer conjugates for coating cells

 #885
20180044417
2018-02-15

Chimeric antigen receptor (CAR) comprising a CD19-binding domain

 #886
20180044404
2018-02-15

IMMUNOMODULATORY FUSION PROTEINS AND USES THEREOF

 #887
20180027783
2018-02-01

Porcine reproductive and respiratory syndrome virus resistant animals

 #888
20180023057
2018-01-25

Cell culture method, cell aggregates, cell aggregation control agent, and medium

 #889
20180021418
2018-01-25

Engineered T cells and uses therefor

 #890
20180016337
2018-01-18

CEACAM6 CAR immune cells to treat cancers

 #891
20180015182
2018-01-18

Engineered exosomes for the delivery of bioactive cargo using transmembrane tetraspanins

 #892
20180002438
2018-01-04

Chimeric antigen receptors, compositions, and methods

 #893
20180002397
2018-01-04

CD33 specific chimeric antigen receptors

 #894
20170368169
2017-12-28

Multispecific and multifunctional molecules and uses thereof

 #895
20170368098
2017-12-28

Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

 #896
20170356010
2017-12-14

Methods and compositions for transducing lymphocytes and regulating the activity thereof

 #897
20170342434
2017-11-30

Chloroplast Expressing Colostrum or Milk Polypeptides

 #898
20170335008
2017-11-23

Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases

 #899
20170333479
2017-11-23

Methods and compositions for natural killer cells

 #900
20170327596
2017-11-16

METHOD